ARCHIVES

ACS Research Budget Over $82 Million

This article is from The Cancer Letter archive.

Vol. 13 No. 29 | July 17, 1987

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

Cancer Center Directors Contemplate the Role of Centers In the 21st Century

May 7, 1999

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

DeVita To Discuss NCI Plans for CCOPs at ACCC Meetings

January 17, 1986